Obesity Clinical Trial
Official title:
Effects of a Combination of Prebiotic Fibres on Weight Loss During an Energy Restricted Diet in an Overweight/Obese Population
The aim of this study is to investigate whether a diet supplemented with two prebiotic fibres
induces greater changes in body weight compared to placebo during 12 weeks of energy
restriction in an obese/overweight population.
The hypothesis is that the fiber-containing dietary supplement will:
1) Induce greater changes in body weight compared to the placebo group 2) change the gut
microbiota composition 3) improve glucose homeostasis 4) decrease serum concentration of
triglycerides, total and LDL cholesterol
The hypothesis is that the effect of the intervention on weight loss will be partly mediated
by the diet-induced changes in the gut microbiota composition.
Prebiotics are nutrients that specifically utilized by the gut microbiota. Beneficial health
effects of prebiotics are generally attributed to 1) stimulation of beneficial bacteria and
SCFA production, and consequently; improved barrier function, regulation of enteroendocrine
peptide secretion and resistance to inflammatory stimuli; 2) modulation of lipid metabolism,
possibly by suppression of lipogenic enzymes and thus decreased synthesis of lipoproteins and
triglycerides; and 3) increased mineral absorption.
Inulin is recognized as a common prebiotic. Fibersol-2 is a resistant starch that has been
suggested to induce satiety, when given in a dose of 10 g. Intake of inulin has been shown to
induce changes in the microbial abundance and increase production of SCFA19; whereas
resistant starch has been shown to improve insulin sensitivity and postprandial glucose
AUC20. However, the effects of an intervention with a combination of these two fibers on
obesity and body composition during an energy restricted diet have not been addressed.
Supplements with other types of fibres in addition to energy restriction have shown
additional effects in weight reduction.
In this study, the effects of a combination product of two prebiotic fibres on additional
weight loss during energy restriction in a placebo-controlled, randomized parallel study with
a duration of 12 weeks will be tested. Furthermore, the effects of the fibres on the gut
microbial composition, markers of metabolic syndrome (MetS) and glucose metabolism will be
tested. The active diet will contain intervention products high in dietary fibre and the
placebo diet will contain maltodextrin. The fiber-containing dietary supplements will add
approximately 20 g of prebiotic fibres per day, where approximately 10 g will be inulin and
approximately 10 g will be resistant maltodextrin. The intervention products and placebo will
be consumed as milk. The fiber-containing dietary supplement is expected to induce additional
weight loss, compared to placebo and to affect the gut microbiome and markers of metabolic
disease.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |